Medication info
Crovastatin 20mg (Rosuvastatin Calcium)

Crovastatin 20mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
Domestic: 28 tablets (14 tablets/PTP X 2), Export: 28 tablets (14 tablets/PTP X 2)
Approval status
Active

MFDS item code 201000980 · Notified 2010.01.28 · Insurance code 671804840

Summary

Main use
Treatment of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased up to a maximum of 20 mg daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or more. Safety and efficacy have not been established in children younger than 10 years.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression

  • Hypercholesterolemia
  • mixed familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary artery disease
  • stroke
  • myocardial infarction
View approved original text

This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia who are not adequately controlled by diet and exercise alone. It is also used with other treatments in patients with homozygous familial hypercholesterolemia to lower cholesterol levels and delay the progression of atherosclerosis. In pediatric patients where mixed familial hypercholesterolemia is not controlled by diet alone, it helps reduce total cholesterol and LDL cholesterol levels. Additionally, it is used in conjunction with diet in patients with primary dysbetalipoproteinemia. Furthermore, in middle-aged and elderly patients with cardiovascular disease risk factors, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization. This medication is used for improving overall blood lipid levels and reducing the risk of cardiovascular disease.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased up to a maximum of 20 mg daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or more. Safety and efficacy have not been established in children younger than 10 years.

Precautions

This drug should not be used by certain patients. For example, individuals who are allergic to this drug, those with severe liver dysfunction, muscle disorders, those taking certain medications, individuals with severe kidney impairment, women who are pregnant or breastfeeding, and those with genetic issues such as lactose intolerance should not take this medication. Furthermore, it is important to regularly check liver function tests and muscle status while taking this medication. Those with a history of liver disease or who consume alcohol heavily should take extra caution, and if symptoms of muscle pain or weakness occur, they should consult a doctor immediately. This drug carries a risk of muscle damage, so care should be taken in individuals with decreased kidney function, hypothyroidism, family history, elderly patients, and alcohol abusers. In addition, caution is needed when taking this drug with certain drugs (e.g., fibrates), as the risk of muscle-related side effects may increase. This drug may affect the liver and muscles, so if abnormal symptoms occur, it should be discontinued immediately and medical advice should be sought. Rarely, serious skin reactions, liver dysfunction, and kidney issues can occur, so immediate treatment is necessary if these symptoms appear. Women who are pregnant or may become pregnant must use appropriate contraceptive methods and should not take this drug during pregnancy. Women who are breastfeeding should also not use this medication for safety reasons. This drug can interact with other medications, so inform healthcare providers of any other medications being taken. Particular caution is required when taken with certain antiviral agents, immunosuppressants, antibiotics, and some cardiovascular drugs. In case of overdose, there is no specific antidote, so treatment should be symptomatic, monitoring liver function and muscle enzyme levels. Lastly, this drug is not known to significantly affect driving or operating machinery, but caution should be taken as symptoms like dizziness may occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced erithematous eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to avoid exposure to air or moisture, preferably at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

Domestic: 28 tablets (14 tablets/PTP X 2), Export: 28 tablets (14 tablets/PTP X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.